Topiramate Capsule, Extended Release
Product Images NDC 70710-1041

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70710-1041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (444d0968 83c5 477b Bb33 352d4a0783b3 01)

Chemical structure diagram of the active ingredient Topiramate, showing its molecular arrangement with labeled atoms and functional groups.*

FDA Label Image

Image (444d0968 83c5 477b Bb33 352d4a0783b3 02)

A Kaplan-Meier curve graph displaying cumulative rates for time to first seizure over 500 days, comparing Topiramate 50 mg/day versus 400 mg/day. The graph uses solid and dashed lines to represent the two dosage groups with patient numbers indicated in the legend, and includes a p-value (0.0002) denoting statistical significance.*

FDA Label Image

Image (444d0968 83c5 477b Bb33 352d4a0783b3 03)

Bar graph comparing the proportion of patients experiencing different ranges of seizure frequency reduction from baseline, for placebo and Topiramate Extended-Release Capsules 200 mg/day. The x-axis shows percentage reduction from baseline in seizure frequency, and the y-axis shows the proportion of patients in percentages.*

FDA Label Image

Image (444d0968 83c5 477b Bb33 352d4a0783b3 04)

A bar chart comparing the change from baseline to double-blind phase in average monthly migraine period rate for placebo and Topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day across two studies (Study 11 and Study 12). The chart shows mean decreases with error bars representing ±SE for each group, with statistical significance indicated for Topiramate doses.*

FDA Label Image

Image (444d0968 83c5 477b Bb33 352d4a0783b3 05)

Topiramate Extended-Release Capsules 25 mg oral dosage form label by Zydus Pharmaceuticals USA Inc. The label indicates a package of 30 capsules with once-daily dosing. It includes storage instructions, child-resistance info, and a pharmacist dispensing note. The NDC number 70710-1039-3 and manufacturer details are present as well.*

FDA Label Image

Image (444d0968 83c5 477b Bb33 352d4a0783b3 06)

Topiramate Extended-Release Capsules 50 mg label from Zydus Pharmaceuticals USA Inc. The label shows the NDC 70710-1040-3 with the dosage form as extended-release capsules for oral use. It includes a note for once-daily dosing, a 30-capsule package size, and directions for pharmacists to dispense the medication guide separately. Additional storage and safety information is present, including child-resistant packaging and recommended storage temperatures.*

FDA Label Image

Image (444d0968 83c5 477b Bb33 352d4a0783b3 07)

Topiramate Extended-Release Capsules 100 mg label from Zydus Pharmaceuticals USA Inc. The label indicates a bottle containing 30 capsules for once-daily dosing. It includes storage instructions, dosage guidance, and cautions, highlighting that the package is child-resistant. The label shows the product NDC 70710-1041-3 and the manufacturer's details in India and USA.*

FDA Label Image

Image (444d0968 83c5 477b Bb33 352d4a0783b3 08)

Topiramate Extended-Release Capsules 150 mg oral dosage form in a package of 30 capsules. The label includes dosage instructions for once-daily dosing and directions for pharmacists to dispense the medication guide. Manufactured by Zydus Lifesciences Ltd., distributed by Zydus Pharmaceuticals USA Inc. The label states the product is Rx only and child-resistant packaging guidelines.*

FDA Label Image

Sl-200mg-30c (444d0968 83c5 477b Bb33 352d4a0783b3 09)

Topiramate Extended-Release Capsules 200 mg, oral dosage form in a bottle label format. The label indicates once-daily dosing with 30 capsules per container. The product is manufactured by Zydus Lifesciences Ltd. and labeled by Zydus Pharmaceuticals USA Inc. Additional details include child-resistant packaging and storage instructions between 20°C to 25°C.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.